Having identified IGFBP3 as a candidate imatinib-targeted gene, we sought to determine whether IGFBP3 directly mediates the cytotoxicity of imatinib in GIST cells. This evidence concerns the gene IGFBP3 and gastrointestinal stromal tumor.